<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR33">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Galasiti Kankanamalage</surname>
    <given-names>AC</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Damalanka</surname>
    <given-names>VC</given-names>
   </name>
   <name>
    <surname>Rathnayake</surname>
    <given-names>AD</given-names>
   </name>
   <name>
    <surname>Fehr</surname>
    <given-names>AR</given-names>
   </name>
   <name>
    <surname>Mehzabeen</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Battaile</surname>
    <given-names>KP</given-names>
   </name>
   <name>
    <surname>Lovell</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Lushington</surname>
    <given-names>GH</given-names>
   </name>
   <name>
    <surname>Perlman</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Structure-guided design of potent and permeable inhibitors of MERS coronavirus 3CL protease that utilize a piperidine moiety as a novel design element</article-title>
  <source>Eur J Med Chem</source>
  <year>2018</year>
  <volume>150</volume>
  <fpage>334</fpage>
  <lpage>346</lpage>
  <?supplied-pmid 29544147?>
  <pub-id pub-id-type="pmid">29544147</pub-id>
 </element-citation>
</ref>
